Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments
Journal of Natural Medicines · 2024
DOI: 10.1007/s11418-024-01781-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Medicines, 2024. Verfasst von Xin Fang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Road, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Glucosides, Ventricular Remodeling, Monoterpenes, Myocardial Infarction. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
This study investigates the cardioprotective effects of Paeoniflorin (PF) on left ventricular remodeling following acute myocardial infarction (AMI) under conditions of hypobaric hypoxia. Left ventricular remodeling post-AMI plays a pivotal role in exacerbating heart failure, especially at high altitudes. Using a rat model of AMI, the study aimed to evaluate the cardioprotective potential of PF under hypobaric hypoxia. Ninety male rats were divided into four groups: sham-operated controls under normoxia/hypobaria, an AMI model group, and a PF treatment group. PF was administered for 4 weeks after AMI induction. Left ventricular function was assessed using cardiac magnetic resonance imaging. Biochemical assays of cuproptosis, oxidative stress, apoptosis, inflammation, and fibrosis were performed. Results demonstrated PF significantly improved left ventricular function and remodeling after AMI under hypobaric hypoxia. Mechanistically, PF decreased FDX1/DLAT expression and serum copper while increasing pyruvate. It also attenuated apoptosis, inflammation, and fibrosis by modulating Bcl-2, Bax, NLRP3, and oxidative stress markers. Thus, PF exhibits therapeutic potential for left ventricular remodeling post-AMI at high altitude by inhibiting cuproptosis, inflammation, apoptosis and fibrosis. Further studies are warranted to optimize dosage and duration and elucidate PF’s mechanisms of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Road, Chengdu, 610041, China.
- Department of Radiology, Ningxia Medical University, Yinchuan, China.
- Molecular Imaging Center, West China Hospital, Sichuan University, Chengdu, China.
- School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
- Department of Radiology, Yushu People's Hospital, Yushu, Qinghai, China.
- Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Road, Chengdu, 610041, China. gaofabao@wchscu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fang, X., Ji, Y., Li, S., Wang, L., He, B., Li, B., Liang, B., Yin, H., Chen, H., Dingda, D., Wu, B., & Gao, F. (2024). Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments. Journal of Natural Medicines. https://doi.org/10.1007/s11418-024-01781-7
Vancouver
Fang X, Ji Y, Li S, Wang L, He B, Li B, et al. Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments. Journal of Natural Medicines. 2024. doi:10.1007/s11418-024-01781-7
BibTeX
@article{Fang2024,
author = {Fang, Xin and Ji, Yaoxuan and Li, Shuang and Wang, Lei and He, Bo and Li, Bo and Liang, Boshen and Yin, Hongke and Chen, Haotian and Dingda, Duojie and Wu, Bing and Gao, Fabao},
title = {Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments},
journal = {Journal of Natural Medicines},
year = {2024},
doi = {10.1007/s11418-024-01781-7}
}
EUVIMED